Recombinant gamma interferon for the treatment of pulmonary and mycobacterial diseases

Recombinant gamma interferon for the treatment of pulmonary and mycobacterial diseases

Bibliographic Details
Format:	Article
Language:	English
Published:	Elfos Scientiae
Series:	Biotecnología Aplicada
Online Access:	http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1027-28522009000200008&lng=en&tlng=en

Similar Items

In vivo and in vitro effects of antituberculosis treatment on mycobacterial interferon-gamma T cell response.
by: Ilaria Sauzullo, et al.
Published: (2009-01-01)

Bortezomib treatment for refractory nontuberculous mycobacterial infection in the setting of interferon gamma autoantibodies
by: Joseph M. Rocco, et al.
Published: (2021-01-01)

Immunomodulation with recombinant interferon-gamma1b in pulmonary tuberculosis.
by: Rod Dawson, et al.
Published: (2009-09-01)

Study on the biosynthesisof recombinant interferon-gamma
by: June-Wei Chen, et al.

Differential Impairment of Interferon-γ Responses in Two Cases of Pulmonary Nontuberculous Mycobacterial Disease
by: William Rae, et al.
Published: (2016-01-01)

Profiling mycobacterial communities in pulmonary nontuberculous mycobacterial disease.
by: Steven A Cowman, et al.
Published: (2018-01-01)

Expression of recombinant gamma interferon in tobacco plant seeds
by: Saber Asghar Zadeh, et al.
Published: (2015-05-01)

Performance of Interferon-Gamma Release Assays in the Diagnosis of Nontuberculous Mycobacterial Diseases—A Retrospective Survey From 2011 to 2019
by: Chi Yang, et al.
Published: (2021-02-01)

Exons Analysis of Interferon-Gamma Receptor 1 Gene in Patients with Mendelian Susceptibility to Mycobacterial Diseases (MSMD) in the Central Region of Iran
by: Roya Sherkat, et al.
Published: (2019-01-01)

Interferon-γ Response of Mycobacterium avium subsp. paratuberculosis Infected Goats to Recombinant and Synthetic Mycobacterial Antigens
by: Heike Köhler, et al.
Published: (2021-03-01)

Anti-Interferon-Gamma Autoantibodies and Human Leukocyte Antigens in Adult Patients with Disseminated Non-Tuberculous Mycobacterial Infections
by: Chih-Yu Chi, et al.
Published: (2013)

Recombinant protein expression of chicken interferon-gamma and its antibodies preparation
by: Fu-Yi Shih, et al.
Published: (2018)

Radiologic Diagnosis of Nontuberculous Mycobacterial Pulmonary Disease
by: Eun-Young Kang
Published: (2021-07-01)

Hospital costs in the US for pulmonary mycobacterial diseases
by: Mehdi Mirsaeidi, et al.
Published: (2015-01-01)

Epidemiology of Pulmonary Nontuberculous Mycobacterial Disease, Japan
by: Ho Namkoong, et al.
Published: (2016-06-01)

The epidemiology of nontuberculous mycobacterial pulmonary disease in the Netherlands
by: Jodie Anne Schildkraut, et al.
Published: (2021-07-01)

Anti-Interferon Gamma Autoantibody Disease
by: Chia Hao Lin, et al.
Published: (2017)

The impact of adjuvant surgical treatment of nontuberculous mycobacterial pulmonary disease on prognosis and outcome
by: Kiyoharu Fukushima, et al.
Published: (2020-06-01)

The use of recombinant gamma interferon associated with pentavalent antimony in therapy for visceral leishmaniasis
by: Roberto Badaro
Published: (1988-11-01)

Interferon-gamma release assay performance in pulmonary and extrapulmonary tuberculosis.
by: Yun Feng, et al.
Published: (2012-01-01)

Role of Race/Ethnicity in Pulmonary Nontuberculous Mycobacterial Disease
by: Benjamin S. Thomas, et al.
Published: (2015-03-01)

Outcomes of adjunctive surgery for nontuberculous mycobacterial pulmonary disease
by: Joong-Yub Kim, et al.
Published: (2021-10-01)

Comparative Gamma Delta T Cell Immunology: A Focus on Mycobacterial Disease in Cattle
by: Brandon L. Plattner, et al.
Published: (2011-01-01)

Post-translational modifications of recombinant human interferon-#gamma# in the CHO 320 cell line
by: Wingrove, Callum Scott
Published: (1993)

Interferon Gamma Release Assays (IGRA) in the Diagnosis of Active Pulmonary Tuberculosis
by: Mona K. EL-Deeb, et al.
Published: (2014-06-01)

Interferon-γ Autoantibodies as Predisposing Factor for Nontuberculous Mycobacterial Infection
by: Florent Valour, et al.
Published: (2016-06-01)

Urinary biomarkers of mycobacterial load and treatment response in pulmonary tuberculosis
by: Qianjing Xia, et al.
Published: (2020-09-01)

Nontuberculous mycobacterial pulmonary disease: an integrated approach beyond antibiotics
by: Paola Faverio, et al.
Published: (2021-05-01)

Nontuberculous Mycobacterial Pulmonary Disease from Mycobacterium hassiacum, Austria
by: Helmut J.F. Salzer, et al.
Published: (2020-11-01)

Prevalence of Nontuberculous Mycobacterial Pulmonary Disease, Germany, 2009–2014
by: Felix C. Ringshausen, et al.
Published: (2016-06-01)

Pulmonary Nontuberculous Mycobacterial Disease, Ontario, Canada, 1998–2010
by: Theodore K. Marras, et al.
Published: (2013-11-01)

Interferon-gamma in leishmaniasis.
by: Peter Epeh Kima, et al.
Published: (2013-06-01)

Interferón gamma recombinante como alternativa terapéutica en niños con artritis idiopática juvenil Recombinant gamma Interferon as a therapeutical alternative in children with juvenile idiopathic arthritis
by: Cecilia Coto Hermosilla, et al.
Published: (2010-03-01)

Non-tuberculous mycobacterial pulmonary infections
by: J.D. Chalmers, et al.
Published: (2018-03-01)

Gamma Interferon and prednisone decreasing-dose therapy in patients with Idiopathic Pulmonary Fibrosis
by: Isis Cayón, et al.

Investigate the use of interferon gamma and interferon gamma inducible protein-10 as potential biomarkers to assess tuberculosis diagnosis and treatment outcome
by: Chiang Ya Hui, et al.
Published: (2013)

Investigation into mycobacterial persistence and early markers of outcome in the treatment of pulmonary tuberculosis
by: Sloan, Derek
Published: (2013)

Can interferon-gamma or interferon-gamma-induced-protein-10 differentiate tuberculosis infection and disease in children of high endemic areas?
by: Mohammed Ahmed Yassin, et al.
Published: (2011-01-01)

Clinical relevance and diagnosis of nontuberculous mycobacterial pulmonary disease in populations at risk
by: Jia-Yih Feng, et al.
Published: (2020-06-01)

Chronic Pulmonary Aspergillosis Following Nontuberculous Mycobacterial Infections: An Emerging Disease
by: Pakpoom Phoompoung, et al.
Published: (2020-12-01)